B. Riley Wealth Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,505
Closed -$4.19K 1630
2024
Q1
$4.19K Sell
15,505
-11,250
-42% -$3.27K ﹤0.01% 1443
2023
Q4
$8.53K Buy
26,755
+11,250
+73% +$2.9K ﹤0.01% 1382
2023
Q3
$4.19K Buy
15,505
+750
+5% +$273 ﹤0.01% 1443
2023
Q2
$7.45K Sell
14,755
-800
-5% -$478 ﹤0.01% 1529
2023
Q1
$10.2K Buy
+15,555
New +$10.5K ﹤0.01% 1488
2021
Q4
Sell
-12,930
Closed -$24K 1509
2021
Q3
$24K Sell
12,930
-5,310
-29% -$11.9K ﹤0.01% 1390
2021
Q2
$58K Buy
18,240
+3,000
+20% +$7.5K ﹤0.01% 1343
2021
Q1
$50K Buy
+15,240
New +$55.2K ﹤0.01% 1327

Other funds holding ASXC

B. Riley Wealth Advisors's ASXC Position: Q2 2024 in Review

B. Riley Wealth Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q2 2024, closing a stake of 15,505 shares — an estimated $4.19K sold.

B. Riley Wealth Advisors first reported a position in ASXC in Q1 2021 and held it in 8 quarters. The position peaked at $58K in Q2 2021. 64 funds tracked by Wall St. Rank hold ASXC as of Q2 2024.

  • B. Riley Wealth Advisors reported no remaining Asensus Surgical, Inc. position as of Q2 2024 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 15,505 Asensus Surgical, Inc. shares in Q2 2024, an estimated $4.19K.
  • B. Riley Wealth Advisors first reported a position in Asensus Surgical, Inc. in Q1 2021 and held it in 8 quarters.
  • B. Riley Wealth Advisors's Asensus Surgical, Inc. position peaked at $58K in Q2 2021.
  • 64 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2024.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2024, filed 19 Aug 2024.